The table below shows BioRestorative Therapies, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$3.81M
-$2.78M
-$2.32M
-$2.38M
-$1.59M
-$813.70K
Capital expenditure
-
$36.40K
-
$60.02K
$109.57K
-
Investing cash flow
$968.45K
$2.37M
-$4.93M
$2.54M
-$109.57K
-
Dividends paid
-
-
-
-
BRTX operating cash flow (10-K history)
BioRestorative Therapies, Inc. reported operating cash flow of -$10.79M for fiscal year 2025. That is down 31.1% from -$8.23M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$2.67M (FY 2013) to -$10.79M. Figures come from the company's audited annual reports as filed with the SEC.